Type 2 diabetes aggravates Alzheimer's disease-associated vascular alterations of the aorta in mice

J Alzheimers Dis. 2015;45(1):127-38. doi: 10.3233/JAD-141008.

Abstract

Vascular risk factors are associated with a higher incidence of dementia. In fact, diabetes mellitus is considered a main risk factor for Alzheimer's disease (AD) and both diseases are characterized by vascular dysfunction. However, the underlying mechanisms remain largely unknown. Here, the effects of high-sucrose-induced type 2 diabetes (T2D) in the aorta of wild type (WT) and triple-transgenic AD (3xTg-AD) mice were investigated. 3xTg-AD mice showed a significant decrease in body weight and an increase in postprandial glycemia, glycated hemoglobin (HbA1c), and vascular nitrotyrosine, superoxide anion (O2•-), receptor for the advanced glycation end products (RAGE) protein, and monocyte chemoattractant protein-1 (MCP-1) levels when compared to WT mice. High-sucrose intake caused a significant increase in body weight, postprandial glycemia, HbA1c, triglycerides, plasma vascular cell adhesion molecule 1 (VCAM-1), and vascular nitrotyrosine, O2•-, RAGE, and MCP-1 levels in both WT and 3xTg-AD mice when compared to the respective control group. Also, a significant decrease in nitric oxide-dependent vasorelaxation was observed in 3xTg-AD and sucrose-treated WT mice. In conclusion, AD and T2D promote similar vascular dysfunction of the aorta, this effect being associated with elevated oxidative and nitrosative stress and inflammation. Also, AD-associated vascular alterations are potentiated by T2D. These findings support the idea that metabolic alterations predispose to the onset and progression of dementia.

Keywords: Alzheimer's disease; aorta; endothelium; inflammation; oxidative stress; type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism
  • Acetylcholine / pharmacology
  • Alzheimer Disease / complications*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology*
  • Amyloid beta-Protein Precursor / genetics
  • Analysis of Variance
  • Animals
  • Aorta / drug effects
  • Aorta / metabolism
  • Aorta / pathology*
  • Diabetes Mellitus, Type 2 / complications*
  • Disease Models, Animal
  • Endothelin-1 / metabolism
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Mutation / genetics
  • Nitroprusside / pharmacology
  • Presenilin-1 / genetics
  • Superoxide Dismutase / metabolism
  • Vasodilator Agents / pharmacology
  • tau Proteins / genetics

Substances

  • Amyloid beta-Protein Precursor
  • Endothelin-1
  • PSEN1 protein, human
  • Presenilin-1
  • Vasodilator Agents
  • tau Proteins
  • Nitroprusside
  • Superoxide Dismutase
  • Acetylcholine